Showing 1,301 - 1,320 results of 8,903 for search 'significant ((((step decrease) OR (((we decrease) OR (nn decrease))))) OR (mean decrease))', query time: 0.37s Refine Results
  1. 1301

    Participant Flowchart. by Jiuming Li (11711375)

    Published 2025
    “…According to the follow-up, 271 (56.7%) were in the exclusive breastfeeding group and the rest in the non-exclusive breastfeeding group (n = 207, 43.3%). A significant decrease in exclusive breastfeeding rate was observed in the prolonged TTP group compared to the short TTP group (OR=0.46, 95% CI: 0.27–0.74). …”
  2. 1302

    Stratified analyses. by Jiuming Li (11711375)

    Published 2025
    “…According to the follow-up, 271 (56.7%) were in the exclusive breastfeeding group and the rest in the non-exclusive breastfeeding group (n = 207, 43.3%). A significant decrease in exclusive breastfeeding rate was observed in the prolonged TTP group compared to the short TTP group (OR=0.46, 95% CI: 0.27–0.74). …”
  3. 1303

    Data for Figs 8A–8H, 9A–9K, 10A–10I. by Xiaohua Zhang (350570)

    Published 2024
    “…In <i>vivo</i> experiments further showed that PRV UL4 (<sup>132</sup>DVAADAAAEAAAAE<sup>145</sup>) mutated strain (PRV-UL4<sup>mut</sup>) infection did not lead to a significant decrease in viral titers at 12 h. p. i, but it induced lower levels of IL-1β, IL-18, and GSDMD-NT, which led to an alleviated inflammatory infiltration and pathological damage in the lungs and brains, and a lower death rate compared with wild-type PRV strain infection. …”
  4. 1304

    Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

    Published 2025
    “…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  5. 1305

    Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

    Published 2025
    “…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  6. 1306

    Store listing metrics and user acquisition. by Henri Claude Moungui (22227043)

    Published 2025
    “…Interrupted time series analyses found gradual adoption and sustained retention following intervention start, but significant decrease at campaign end.</p><p>Conclusion</p><p>A context‑adapted, multi‑channel marketing strategy markedly improved adoption and retention of the WHO SkinNTDs app among Cameroonian FHWs. …”
  7. 1307

    Installation, growth, and retention metrics. by Henri Claude Moungui (22227043)

    Published 2025
    “…Interrupted time series analyses found gradual adoption and sustained retention following intervention start, but significant decrease at campaign end.</p><p>Conclusion</p><p>A context‑adapted, multi‑channel marketing strategy markedly improved adoption and retention of the WHO SkinNTDs app among Cameroonian FHWs. …”
  8. 1308

    Implemented activities. by Henri Claude Moungui (22227043)

    Published 2025
    “…Interrupted time series analyses found gradual adoption and sustained retention following intervention start, but significant decrease at campaign end.</p><p>Conclusion</p><p>A context‑adapted, multi‑channel marketing strategy markedly improved adoption and retention of the WHO SkinNTDs app among Cameroonian FHWs. …”
  9. 1309

    App user retention trends. by Henri Claude Moungui (22227043)

    Published 2025
    “…Interrupted time series analyses found gradual adoption and sustained retention following intervention start, but significant decrease at campaign end.</p><p>Conclusion</p><p>A context‑adapted, multi‑channel marketing strategy markedly improved adoption and retention of the WHO SkinNTDs app among Cameroonian FHWs. …”
  10. 1310

    Sampling locations for banana aphids. by Aime Cheoh Enoh (20141758)

    Published 2024
    “…Four isolates (BIITAC6.2.2, BIITAC10.3.3, BIITAC8.1.5, and MIITAC6.2.2) were highly pathogenic, causing greater than 75% aphid mortality in all populations. A significant decrease in aphid fecundity was observed with BIITAC6.2.2, MIITAC6.2.2, and BIITAC10.3.3. …”
  11. 1311

    App user onboarding trends. by Henri Claude Moungui (22227043)

    Published 2025
    “…Interrupted time series analyses found gradual adoption and sustained retention following intervention start, but significant decrease at campaign end.</p><p>Conclusion</p><p>A context‑adapted, multi‑channel marketing strategy markedly improved adoption and retention of the WHO SkinNTDs app among Cameroonian FHWs. …”
  12. 1312

    App user base growth trends. by Henri Claude Moungui (22227043)

    Published 2025
    “…Interrupted time series analyses found gradual adoption and sustained retention following intervention start, but significant decrease at campaign end.</p><p>Conclusion</p><p>A context‑adapted, multi‑channel marketing strategy markedly improved adoption and retention of the WHO SkinNTDs app among Cameroonian FHWs. …”
  13. 1313

    <i>SLC2A2</i> is essential for liver differentiation in developing vertebrates by Yejin Kim (740789)

    Published 2025
    “…Data are represented as mean ± standard error of the mean (SEM). (G) Quantitative RT-PCR analysis was performed to evaluate the expression levels of igf1r. …”
  14. 1314

    DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
  15. 1315

    DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
  16. 1316

    DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
  17. 1317

    DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
  18. 1318
  19. 1319

    Juvenile demyelination induces a loss of functional autapses. by Sara Hijazi (21656615)

    Published 2025
    “…Cuprizone-treated mice show a significant decrease in the percentage of cells showing an autaptic response (<i>Fisher’s exact test; *p = 0.0173</i>). …”
  20. 1320

    AUT00201 (1 µM) can rescue AP width in cuprizone mice. by Sara Hijazi (21656615)

    Published 2025
    “…In the responsive cells from cuprizone mice (red) a significant increase in PV interneuron firing frequency at lower current steps (gray) was observed (<i>group x current two-way repeated measures: n = 8 cells from 4 mice: p = 0.05287; AUT00201 effect: F(1,60) = 5.050, *p = 0.0457. …”